IMMU - Immunomedics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $96.76. This is a potential upside of $8.9 (10.13%) from yesterday's end of day stock price of $87.86.

Immunomedics's activity chart (see below) currently has 89 price targets and 54 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 95.83% with an average time for these price targets to be met of 169 days.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$55

4 years 10 months 24 days ago
(15-Sep-2020)

5/6 (83.33%)

$11.69 (26.99%)

66

Hold

$55

4 years 10 months 25 days ago
(14-Sep-2020)

6/6 (100%)

$14.37 (35.37%)

265

Hold

$56

4 years 10 months 25 days ago
(14-Sep-2020)

8/8 (100%)

$14.84 (36.05%)

163

$40

$-47.86 (-54.47%)

$19

4 years 11 months 29 days ago
(10-Aug-2020)

5/5 (100%)

$-0.92 (-2.25%)

252

Buy

$55

$-32.86 (-37.40%)

$45

5 years 2 days ago
(06-Aug-2020)

9/9 (100%)

$11.82 (27.37%)

107

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMMU (Immunomedics) average time for price targets to be met?

On average it took 169 days on average for the stock forecasts to be realized with a an average price target met ratio 95.83

Which analyst has the current highest performing score on IMMU (Immunomedics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on IMMU (Immunomedics)?

Raghuram Selvaraju has 10 price targets and 12 ratings on IMMU

Which analyst is the currently most bullish on IMMU (Immunomedics)?

Raghuram Selvaraju with highest potential upside - $0

Which analyst is the currently most reserved on IMMU (Immunomedics)?

Matthew Andrews with lowest potential downside - -$65.86

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?